HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Whipple's disease diagnosed during anti-tumor necrosis factor alpha treatment: two case reports and review of the literature.

AbstractINTRODUCTION:
Whipple's disease is a rare infectious disease caused by Tropheryma whipplei with protean clinical manifestations. This infection may mimic chronic inflammatory rheumatisms.
CASE PRESENTATION:
We report two cases of Whipple's disease diagnosed in the context of an inflammatory disease with anti-tumor necrosis factor alpha failure. The first patient was a 58-year-old white man with psoriatic spondylarthritis, who was treated with adalimumab, etanercept, infliximab, tocilizumab and golimumab. The second was a 73-year-old white man with rheumatoid arthritis, who received treatment with infliximab, then etanercept and rituximab.
CONCLUSIONS:
Whipple's disease should be suspected in all patients diagnosed with chronic inflammatory rheumatism, partially controlled or not controlled by treatment with tumor necrosis factor alpha blockers, whose condition worsens after treatment.
AuthorsJose M Ramos, Francisco Pasquau, Nora Galipienso, Beatriz Valero, Angela Navarro, Agustín Martinez, José Rosas, Ana Gutiérrez, Rosario Sanchez-Martínez
JournalJournal of medical case reports (J Med Case Rep) Vol. 9 Pg. 165 (Jul 28 2015) ISSN: 1752-1947 [Electronic] England
PMID26215452 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Rituximab
  • golimumab
  • Infliximab
  • Adalimumab
  • tocilizumab
  • Etanercept
Topics
  • Adalimumab (therapeutic use)
  • Aged
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antirheumatic Agents (therapeutic use)
  • Diagnosis, Differential
  • Etanercept (therapeutic use)
  • Humans
  • Infliximab (therapeutic use)
  • Male
  • Middle Aged
  • Rheumatic Fever (complications, drug therapy)
  • Rituximab (therapeutic use)
  • Tumor Necrosis Factor-alpha (drug effects)
  • Whipple Disease (complications, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: